Metoclopramide Hydrochloride

Drug Usage Statistics, United States, 2006 - 2016

Number of Prescriptions Over Time (2006 - 2016)

Rank of Top Drugs Over Time

"Rank" refers to the frequency that a given medication is prescribed within a calendar year compared to all other medications. A rank of "4" would indicate that the medication was the fourth most commonly prescribed medication.

Year Rank Change
2006 156  19
2007 136  20
2008 109  27
2009 137  28
2010 161  24
2011 214  53
Year Rank Change
2012 225  11
2013 233  8
2014 270  37
2015 286  16
2016 250  36

Patient Out-Of-Pocket Cost Over Time (2006 - 2016)

"Out-of-pocket" cost refers to the payment made by the patient (either cash price or the copay amount). This value does not include reimbursement from a third party payer (eg, Medicare or private insurance) and does not represent the total drug cost.

Usage Statistics of Related Drugs

Drug Name Total Prescriptions (2016)
Metoclopramide Hydrochloride (this drug) 1,877,953

Drug Synonyms

Drug synonyms are used during the sanitation and standardization process of "cleaning" the original data source (MEPS). Occassionally, brand names may be listed below that are no longer on the market or are very infrequently used.

Brand Name Synonyms
  • "Clopra-""Yellow"""
  • Clopra
  • Maxolon
  • Metoclopramide
  • Metoclopramide Intensol
  • Metozolv Odt
  • Reglan
  • Reglan Odt
Generic Drug Synonyms and Salts
  • Metoclopramide Hydrochloride

FDA Approval Information

Established Pharmacologic Class (EPC): Dopamine-2 Receptor Antagonist
Initial FDA approval date: Prior to January 1, 1982
First FDA applicant: Discn
First dosage form: Injectable (injection)

Prescription data source: Medical Expenditure Panel Survey (MEPS) 2006-2016. Agency for Healthcare Research and Quality (AHRQ), Rockville, MD. ClinCalc DrugStats Database version 19.1. Read more about the ClinCalc DrugStats database.


Related Links

Follow Us!

New and Popular


Open Menu

Cite This Page

Show AMA citation

©2019 - ClinCalc LLC. All rights reserved.
Disclaimer - Privacy Policy - Contact Us
Updated Jul 19, 2018
Back to Top